Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases

Simona Serini,1,2,* Roberta Cassano,3,* Sonia Trombino,3 Gabriella Calviello1,2 1Institute of General Pathology, Università Cattolica del Sacro Cuore, 00168 Roma, Italy; 2Fondazione Policlinico Universitario A, Gemelli 00168 Roma, Italy; 3Department of Pharmacy, Health and Nutritional Sc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Serini S, Cassano R, Trombino S, Calviello G
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/d876efa9bed84aaa9e047765768c9672
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d876efa9bed84aaa9e047765768c9672
record_format dspace
spelling oai:doaj.org-article:d876efa9bed84aaa9e047765768c96722021-12-02T04:22:59ZNanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases1178-2013https://doaj.org/article/d876efa9bed84aaa9e047765768c96722019-04-01T00:00:00Zhttps://www.dovepress.com/nanomedicine-based-formulations-containing-omega-3-polyunsaturated-fat-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Simona Serini,1,2,* Roberta Cassano,3,* Sonia Trombino,3 Gabriella Calviello1,2 1Institute of General Pathology, Università Cattolica del Sacro Cuore, 00168 Roma, Italy; 2Fondazione Policlinico Universitario A, Gemelli 00168 Roma, Italy; 3Department of Pharmacy, Health and Nutritional Sciences, Università della Calabria, 87036 Cosenza, Italy *These authors contributed equally to this work Abstract: Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) are dietary factors involved in the prevention of cardiovascular, inflammatory, and neoplastic diseases. A multidisciplinary approach – based on recent findings in nutritional science, lipid biochemistry, biotechnology, and biology of inflammation and cancer – has been recently employed to develop ω-3 PUFA-containing nanoformulations with an aim to protect these fatty acids from degradation, increase their bioavailability and delivery to target tissues, and, thus, enhance their bioactivity. In some cases, these nanoformulations were designed to administer ω-3 PUFAs in combination with other nutraceuticals or conventional/innovative drugs. The aim of this strategy was to increase the activities of the compounds contained in the nanoformulation and to reduce the adverse effects often induced by drugs. We herein analyze the results of papers evaluating the potential use of ω-3 PUFA-containing nanomaterials in fighting cardiovascular diseases and cancer. Future directions in this field of research are also provided. Keywords: innovative biotechnologies, cardiovascular diseases, nanoparticles, ω-3 PUFAs, cancer  Serini SCassano RTrombino SCalviello GDove Medical PressarticleInnovative biotechnologiesCardiovascular diseasesNanoparticlesω-3 PUFAsCancerMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 2809-2828 (2019)
institution DOAJ
collection DOAJ
language EN
topic Innovative biotechnologies
Cardiovascular diseases
Nanoparticles
ω-3 PUFAs
Cancer
Medicine (General)
R5-920
spellingShingle Innovative biotechnologies
Cardiovascular diseases
Nanoparticles
ω-3 PUFAs
Cancer
Medicine (General)
R5-920
Serini S
Cassano R
Trombino S
Calviello G
Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
description Simona Serini,1,2,* Roberta Cassano,3,* Sonia Trombino,3 Gabriella Calviello1,2 1Institute of General Pathology, Università Cattolica del Sacro Cuore, 00168 Roma, Italy; 2Fondazione Policlinico Universitario A, Gemelli 00168 Roma, Italy; 3Department of Pharmacy, Health and Nutritional Sciences, Università della Calabria, 87036 Cosenza, Italy *These authors contributed equally to this work Abstract: Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) are dietary factors involved in the prevention of cardiovascular, inflammatory, and neoplastic diseases. A multidisciplinary approach – based on recent findings in nutritional science, lipid biochemistry, biotechnology, and biology of inflammation and cancer – has been recently employed to develop ω-3 PUFA-containing nanoformulations with an aim to protect these fatty acids from degradation, increase their bioavailability and delivery to target tissues, and, thus, enhance their bioactivity. In some cases, these nanoformulations were designed to administer ω-3 PUFAs in combination with other nutraceuticals or conventional/innovative drugs. The aim of this strategy was to increase the activities of the compounds contained in the nanoformulation and to reduce the adverse effects often induced by drugs. We herein analyze the results of papers evaluating the potential use of ω-3 PUFA-containing nanomaterials in fighting cardiovascular diseases and cancer. Future directions in this field of research are also provided. Keywords: innovative biotechnologies, cardiovascular diseases, nanoparticles, ω-3 PUFAs, cancer  
format article
author Serini S
Cassano R
Trombino S
Calviello G
author_facet Serini S
Cassano R
Trombino S
Calviello G
author_sort Serini S
title Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
title_short Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
title_full Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
title_fullStr Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
title_full_unstemmed Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
title_sort nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/d876efa9bed84aaa9e047765768c9672
work_keys_str_mv AT serinis nanomedicinebasedformulationscontainingomega3polyunsaturatedfattyacidspotentialapplicationincardiovascularandneoplasticdiseases
AT cassanor nanomedicinebasedformulationscontainingomega3polyunsaturatedfattyacidspotentialapplicationincardiovascularandneoplasticdiseases
AT trombinos nanomedicinebasedformulationscontainingomega3polyunsaturatedfattyacidspotentialapplicationincardiovascularandneoplasticdiseases
AT calviellog nanomedicinebasedformulationscontainingomega3polyunsaturatedfattyacidspotentialapplicationincardiovascularandneoplasticdiseases
_version_ 1718401276656484352